Altimmune Stock Market Value
| ALT Stock | USD 4.27 0.11 2.64% |
| Symbol | Altimmune |
Is there potential for Biotechnology market expansion? Will Altimmune introduce new products? Factors like these will boost the valuation of Altimmune. If investors know Altimmune will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Altimmune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Altimmune is measured differently than its book value, which is the value of Altimmune that is recorded on the company's balance sheet. Investors also form their own opinion of Altimmune's value that differs from its market value or its book value, called intrinsic value, which is Altimmune's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Altimmune's market value can be influenced by many factors that don't directly affect Altimmune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Altimmune's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Altimmune represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Altimmune's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Altimmune 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Altimmune's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Altimmune.
| 12/05/2025 |
| 03/05/2026 |
If you would invest 0.00 in Altimmune on December 5, 2025 and sell it all today you would earn a total of 0.00 from holding Altimmune or generate 0.0% return on investment in Altimmune over 90 days. Altimmune is related to or competes with Aprea Therapeutics, Adial Pharmaceuticals, Kiora Pharmaceuticals, Cardio Diagnostics, and Phio Pharmaceuticals. Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver dise... More
Altimmune Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Altimmune's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Altimmune upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 33.68 | |||
| Value At Risk | (6.22) | |||
| Potential Upside | 9.22 |
Altimmune Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Altimmune's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Altimmune's standard deviation. In reality, there are many statistical measures that can use Altimmune historical prices to predict the future Altimmune's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.39) | |||
| Treynor Ratio | (0.21) |
Altimmune March 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.20) | |||
| Mean Deviation | 3.54 | |||
| Coefficient Of Variation | (4,678) | |||
| Standard Deviation | 5.74 | |||
| Variance | 32.94 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.39) | |||
| Treynor Ratio | (0.21) | |||
| Maximum Drawdown | 33.68 | |||
| Value At Risk | (6.22) | |||
| Potential Upside | 9.22 | |||
| Skewness | (0.36) | |||
| Kurtosis | 5.24 |
Altimmune Backtested Returns
Altimmune secures Sharpe Ratio (or Efficiency) of -0.0287, which signifies that the company had a -0.0287 % return per unit of risk over the last 3 months. Altimmune exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Altimmune's Mean Deviation of 3.54, standard deviation of 5.74, and Risk Adjusted Performance of (0.01) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.63, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Altimmune's returns are expected to increase less than the market. However, during the bear market, the loss of holding Altimmune is expected to be smaller as well. At this point, Altimmune has a negative expected return of -0.17%. Please make sure to confirm Altimmune's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Altimmune performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.55 |
Modest predictability
Altimmune has modest predictability. Overlapping area represents the amount of predictability between Altimmune time series from 5th of December 2025 to 19th of January 2026 and 19th of January 2026 to 5th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Altimmune price movement. The serial correlation of 0.55 indicates that about 55.0% of current Altimmune price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.55 | |
| Spearman Rank Test | 0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 0.26 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Altimmune Stock Analysis
When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.